Alangari AA (2014) Corticosteroids in the treatment of acute asthma. Ann Thorac Med 9(4):187–192

Article  PubMed  CAS  PubMed Central  Google Scholar 

Australian Bureau of Statistics (2020–21) Asthma, ABS. https://www.abs.gov.au/statistics/health/health-conditions-and-risks/asthma/latest-release. Accessed 13 Dec 2022

Barcik W, Boutin RCT, Sokolowska M, Finlay BB (2020) The role of lung and gut microbiota in the pathology of asthma. Immunity 52(2):241–255

Article  PubMed  CAS  PubMed Central  Google Scholar 

Barnes PJ (2006) How corticosteroids control inflammation: Quintiles Prize Lecture 2005. Br J Pharmacol 148(3):245–254

Article  PubMed  CAS  PubMed Central  Google Scholar 

Barnes PJ (2010) Inhaled corticosteroids. Pharmaceuticals (Basel) 3(3):514–540

Article  PubMed  CAS  Google Scholar 

Belden Z, Deiuliis JA, Dobre M, Rajagopalan S (2017) The role of the mineralocorticoid receptor in inflammation: focus on kidney and vasculature. Am J Nephrol 46(4):298–314

Article  PubMed  CAS  Google Scholar 

Benninger MS, Waters H (2009) Montelukast: pharmacology, safety, tolerability and efficacy. Clinical Medicine Therapeutics 1:CMT.S1147

Article  Google Scholar 

Berger A (1999) What are leukotrienes and how do they work in asthma? BMJ 319(7202):90

Article  PubMed  CAS  PubMed Central  Google Scholar 

Brusselle GG, Vanderstichele C, Jordens P, Deman R, Slabbynck H, Ringoet V, Verleden G, Demedts IK, Verhamme K, Delporte A, Demeyere B, Claeys G, Boelens J, Padalko E, Verschakelen J, Van Maele G, Deschepper E, Joos GF (2013) Azithromycin for prevention of exacerbations in severe asthma (AZISAST): a multicentre randomised double-blind placebo-controlled trial. Thorax 68(4):322–329

Article  PubMed  Google Scholar 

Bucca C, Rolla G (1989) Mucosal oedema and airway hyperreactivity. Eur Respir J Suppl 6:520s-s522

PubMed  CAS  Google Scholar 

Chellappan DK, Sze Ning QL, Su Min SK, Bin SY, Chern PJ, Shi TP, Ee Mei SW, Yee TH, Qi OJ, Thangavelu L, Rajeshkumar S, Negi P, Chellian J, Wadhwa R, Gupta G, Collet T, Hansbro PM, Dua K (2019) Interactions between microbiome and lungs: paving new paths for microbiome based bio-engineered drug delivery systems in chronic respiratory diseases. Chem Biol Interact 310:108732

Article  PubMed  CAS  Google Scholar 

Chen H, Sun J, Huang Q, Liu Y, Yuan M, Ma C, Yan H (2021) Inhaled corticosteroids and the pneumonia risk in patients with chronic obstructive pulmonary disease: a meta-analysis of randomized controlled trials. Front Pharmacol 12:691621

Article  PubMed  CAS  PubMed Central  Google Scholar 

Choi ID, Ryu JH, Lee DE, Lee MH, Shim JJ, Ahn YT, Sim JH, Huh CS, Shim WS, Yim SV, Chung EK, Lee KT (2016) Enhanced absorption study of ginsenoside compound K (20-O-β-(D-glucopyranosyl)-20(S)-protopanaxadiol) after oral administration of fermented red ginseng extract (HYFRG™) in healthy Korean volunteers and rats. Evid Based Complement Alternat Med 2016:3908142

Article  PubMed  PubMed Central  Google Scholar 

Cohen Z, Kelly L (2022) Bioaccumulation as a mechanism of microbiome/drug interactions. Trends Microbiol 30(2):99–101

Article  PubMed  CAS  Google Scholar 

Combs MP, Wheeler DS, Luth JE, Falkowski NR, Walker NM, Erb-Downward JR, Lama VN, Dickson RP (2021) Lung microbiota predict chronic rejection in healthy lung transplant recipients: a prospective cohort study. Lancet Respir Med 9(6):601–612

Article  PubMed  CAS  PubMed Central  Google Scholar 

Cussotto S, Walsh J, Golubeva AV, Zhdanov AV, Strain CR, Fouhy F, Stanton C, Dinan TG, Hyland NP, Clarke G, Cryan JF, Griffin BT (2021) The gut microbiome influences the bioavailability of olanzapine in rats. EBioMedicine 66:103307

Article  PubMed  CAS  PubMed Central  Google Scholar 

Drew RH, Gallis HA (1992) Azithromycin–spectrum of activity, pharmacokinetics, and clinical applications. Pharmacotherapy 12(3):161–173

Article  PubMed  CAS  Google Scholar 

Durack J, Lynch SV, Nariya S, Bhakta NR, Beigelman A, Castro M, Dyer AM, Israel E, Kraft M, Martin RJ, Mauger DT, Rosenberg SR, Sharp-King T, White SR, Woodruff PG, Avila PC, Denlinger LC, Holguin F, Lazarus SC, Lugogo N, Moore WC, Peters SP, Que L, Smith LJ, Sorkness CA, Wechsler ME, Wenzel SE, Boushey HA, Huang YJ (2017) Features of the bronchial bacterial microbiome associated with atopy, asthma, and responsiveness to inhaled corticosteroid treatment. J Allergy Clin Immunol 140(1):63–75

Article  PubMed  CAS  Google Scholar 

Enaud R, Prevel R, Ciarlo E, Beaufils F, Wieërs G, Guery B, Delhaes L (2020) The gut-lung axis in health and respiratory diseases: a place for inter-organ and inter-kingdom crosstalks. Front Cell Infect Microbiol 10:9

Article  PubMed  CAS  PubMed Central  Google Scholar 

Essilfie AT, Simpson JL, Horvat JC, Preston JA, Dunkley ML, Foster PS, Gibson PG, Hansbro PM (2011) Haemophilus influenzae infection drives IL-17-mediated neutrophilic allergic airways disease. PLoS Pathog 7(10):e1002244

Article  PubMed  CAS  PubMed Central  Google Scholar 

Essilfie AT, Simpson JL, Dunkley ML, Morgan LC, Oliver BG, Gibson PG, Foster PS, Hansbro PM (2012) Combined Haemophilus influenzae respiratory infection and allergic airways disease drives chronic infection and features of neutrophilic asthma. Thorax 67(7):588–599

Article  PubMed  Google Scholar 

Fanta CH (2022) Treatment of intermittent and mild persistent asthma in adolescents and adults, UpToDate. www.uptodate.com. Accessed 13 Dec 2022

Gibson PG, Yang IA, Upham JW, Reynolds PN, Hodge S, James AL, Jenkins C, Peters MJ, Marks GB, Baraket M, Powell H, Taylor SL, Leong LEX, Rogers GB, Simpson JL (2017) Effect of azithromycin on asthma exacerbations and quality of life in adults with persistent uncontrolled asthma (AMAZES): a randomised, double-blind, placebo-controlled trial. Lancet 390(10095):659–668

Article  PubMed  CAS  Google Scholar 

Global Initiative for Asthma (2022) Global strategy for asthma management and prevention. www.ginasthma.org. Accessed 10/09/2022

Goldman P, Peppercorn MA, Goldin BR (1974) Metabolism of drugs by microorganisms in the intestine. Am J Clin Nutr 27(11):1348–1355

Article  PubMed  CAS  Google Scholar 

Goleva E, Jackson LP, Harris JK, Robertson CE, Sutherland ER, Hall CF, Good JT Jr, Gelfand EW, Martin RJ, Leung DY (2013) The effects of airway microbiome on corticosteroid responsiveness in asthma. Am J Respir Crit Care Med 188(10):1193–1201

Article  PubMed  CAS  PubMed Central  Google Scholar 

Green RJ (2006) Leukotriene receptor antagonists in patients with asthma and allergic rhinitis: review article. Curr Allergy Clin Immunol 19(4):176–178

Google Scholar 

Hartmann JE, Albrich WC, Dmitrijeva M, Kahlert CR (2021) The effects of corticosteroids on the respiratory microbiome: a systematic review. Front Med (Lausanne) 8:588584

Article  PubMed  Google Scholar 

Henderson I, Caiazzo E, McSharry C, Guzik TJ, Maffia P (2020) Why do some asthma patients respond poorly to glucocorticoid therapy? Pharmacol Res 160:105189

Article  PubMed  CAS  PubMed Central  Google Scholar 

Hiles SA, McDonald VM, Guilhermino M, Brusselle GG, Gibson PG (2019) Does maintenance azithromycin reduce asthma exacerbations? An individual participant data meta-analysis. European Respiratory Journal, p. 1901381

Hitchings R, Kelly L (2019) Predicting and understanding the human microbiome’s impact on pharmacology. Trends Pharmacol Sci 40(7):495–505

Article  PubMed  CAS  PubMed Central  Google Scholar 

Jarvis B, Markham A (2000) Montelukast: a review of its therapeutic potential in persistent asthma. Drugs 59(4):891–928

Article  PubMed  CAS  Google Scholar 

Jenkins C (2019) Barriers to achieving asthma control in adults: evidence for the role of tiotropium in current management strategies. Ther Clin Risk Manag 15:423–435

Article  PubMed  CAS  PubMed Central  Google Scholar 

Joos S, Miksch A, Szecsenyi J, Wieseler B, Grouven U, Kaiser T, Schneider A (2008) Montelukast as add-on therapy to inhaled corticosteroids in the treatment of mild to moderate asthma: a systematic review. Thorax 63(5):453–462

Article  PubMed  CAS  Google Scholar 

Klünemann M, Andrejev S, Blasche S, Mateus A, Phapale P, Devendran S, Vappiani J, Simon B, Scott TA, Kafkia E, Konstantinidis D, Zirngibl K, Mastrorilli E, Banzhaf M, Mackmull M-T, Hövelmann F, Nesme L, Brochado AR, Maier L, Bock T, Periwal V, Kumar M, Kim Y, Tramontano M, Schultz C, Beck M, Hennig J, Zimmermann M, Sévin DC, Cabreiro F, Savitski MM, Bork P, Typas A, Patil KR (2021) Bioaccumulation of therapeutic drugs by human gut bacteria. Nature 597(7877):533–538

Article  PubMed  PubMed Central  Google Scholar 

Koppel N, Maini Rekdal V, Balskus EP (2017) Chemical transformation of xenobiotics by the human gut microbiota’. Science 356(6344):eaag2770

Article  PubMed  Google Scholar 

Leitao Filho FS, Takiguchi H, Akata K, Ra SW, Moon JY, Kim HK, Cho Y, Yamasaki K, Milne S, Yang J, Yang CWT, Li X, Nislow C, van Eeden SF, Shaipanich T, Lam S, Leung JM, Sin DD (2021) Effects of inhaled corticosteroid/long-acting β(2)-agonist combination on the airway microbiome of patients with chronic obstructive pulmonary disease: a randomized controlled clinical trial (DISARM). Am J Respir Crit Care Med 204(10):1143–1152

Article  PubMed  Google Scholar